Stoneridge Investment Partners’s St Jude Medical STJ Stock Holding History

Stoneridge Investment Partners’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-28,761	Closed	-$2.29M	–	364
2016 Q3	$2.29M	Sell	28,761 -120,091	-81%	-$9.7M	0.33%	108
2016 Q2	$11.6M	Buy	148,852 +7,797	+6%	+$556K	1.73%	6
2016 Q1	$7.76M	Sell	141,055 -3,900	-3%	-$212K	1.14%	20
2015 Q4	$8.95M	Sell	144,955 -19,090	-12%	-$1.2M	1.21%	13
2015 Q3	$10.3M	Buy	+164,045	New	+$11.7M	1.45%	14
2015 Q2	–	Sell	-252,132	Closed	-$16.5M	–	319
2015 Q1	$16.5M	Buy	+252,132	New	+$16.8M	1.93%	9
2014 Q4	–	Sell	-77,993	Closed	-$4.69M	–	299
2014 Q3	$4.69M	Buy	+77,993	New	+$5.1M	0.7%	42

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stoneridge Investment Partners's STJ Position: Q4 2016 in Review

Stoneridge Investment Partners sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 28,761 shares — an estimated $2.29M sold.

Stoneridge Investment Partners first reported a position in STJ in Q3 2014 and held it in 7 quarters. The position peaked at $16.5M in Q1 2015. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

Stoneridge Investment Partners reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
Stoneridge Investment Partners sold 28,761 St Jude Medical shares in Q4 2016, an estimated $2.29M.
Stoneridge Investment Partners first reported a position in St Jude Medical in Q3 2014 and held it in 7 quarters.
Stoneridge Investment Partners's St Jude Medical position peaked at $16.5M in Q1 2015.
551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Stoneridge Investment Partners's 13F filing for Q4 2016, filed 27 Jan 2017.